Cite
MLA Citation
Benjamin A Fisher et al.. “Namilumab or infliximab compared with standard of care in hospitalised patients with COVID-19 (CATALYST): a randomised, multicentre, multi-arm, multistage, open-label, adaptive, phase 2, proof-of-concept trial.” Lancet, vol. 10, no. 3, 2022, pp. 255–266. http://access.bl.uk/ark:/81055/vdc_100152621262.0x00000a